Host: Paul Paik, MD Guest: Jyoti D. Patel, MD, FASCO Lung cancer remains the most common cancer in the United States and Europe and second most common in Japan. Of patients with non-small cell lung cancer (NSCLC), approximately 3% to 4% have tumors

Guest: Robert Gottlieb, MD, PhD, FACC Guest: Marilyn Bulloch, PharmD, BCPS, FCCM Guest: Tesha Seabra, MSN, RN Host: Mimi Secor, DNP, FNP-BC, FAANP Neutralizing monoclonal antibodies (mAbs) first received emergency use authorization (EUA) in Nov

Host: Joseph F. Goldberg, MD, MS Guest: Larry Culpepper, MD, MPH Guest: Andrew A. Nierenberg, MD Bipolar depression remains a burden for patients living with bipolar I disorder. Therefore, faculty experts came together on World Bipolar Day in a c

Host: Shannon L. Meeks, MD Guest: Jonathan C. Roberts, MD Dr. Shannon Meeks and Dr. Jonathan Roberts give an overview of the treatments used for the management of hemophilia A and discuss the safety and efficacy of these treatments. Using a patient

Host: Javed Butler, MD, MPH, MBA Guest: Paul W. Armstrong, MD Finding the optimal treatment strategy for patients with worsening heart failure with reduced ejection fraction (HFrEF) can be challenging, and long-term outcomes are poor. Can newer the

Host: Neil Bressler, MD Hear the world-renowned Dr. Neil Bressler discuss the important role you can play in saving vision when wet AMD strikes. Scroll down to download our Wet AMD handout, so you can share it with your patients! The handout includes

Host: Lee P. Shulman, MD, FACMG, FACOG Guest: Barbara Dehn Physicians continue to seek the safest and most effective formulations for combined hormonal contraceptives (CHCs). The goal is to ensure that the patient’s chosen option optimizes the many

Host: Shannon L. Meeks, MD Guest: Cindy Leissinger, MD Pharmacovigilance begins after clinical trials end and new therapies enter everyday practice. Due to the rarity of hemophilia, participation in clinical trials has necessarily been small, and s

Host: Floor J. Backes, MD Guest: Robert L. Coleman, MD, FACOG, FACS Does immunotherapy play a role in improving quality of life and survival for patients with ovarian cancer? Learn how experts are determining immunotherapy’s place in the treatment

Host: Federico Cappuzzo Guest: Professor Solange Peters Guest: Professor Yi-Long Wu Are dMMR and MSI-H both markers that will soon replace or work in conjunction with PD-L1 when determining immunotherapy for patients with metastatic NSCLC? Accura